Sinil, Hanseo and Rexgene Biotech Undertake R&D Efforts on Novel Treatments

Under the government initiatives to drive the development of novel pharmaceutical and biotechnology based treatments, three domestic companies Sinil Pharm, Hanseo Pharm, and Rexgene Biotech have recently made the project-based research and development agreements with the Ministry of Commerce, Industry and Energy (MOCIE).

Based on the agreement details, Sinil Pharm will participate in the d...